Polish Agency Awarded Grant for Annamycin Clinical Trial for STS
TBIT / Pixabay

Polish Agency Awarded Grant for Annamycin Clinical Trial for STS

In a recent press release, pharmaceutical company Moleculin Biotech, Inc. ("Moleculin") shared a recent advance in the sphere of medical and health research. Agencja Badań Medycznych, a Polish agency which contributes…

Continue Reading Polish Agency Awarded Grant for Annamycin Clinical Trial for STS

Study of the Week: New Genetic Predisposition Variants in Rhabdomyosarcoma

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: New Genetic Predisposition Variants in Rhabdomyosarcoma
New Research Highlights the Link Between Duchenne Muscular Dystrophy and Rhabdomyosarcoma
felixioncool / Pixabay

New Research Highlights the Link Between Duchenne Muscular Dystrophy and Rhabdomyosarcoma

According to a story from bioengineer.org, it has long been known that people with the rare disorder Duchenne muscular dystrophy are at a greater risk of developing a rare cancer…

Continue Reading New Research Highlights the Link Between Duchenne Muscular Dystrophy and Rhabdomyosarcoma
For the First Time in 30 Years: A New Advancement in Rhabdomyosarcoma Treatment
https://pixabay.com/en/baby-care-child-cute-hand-face-20339/

For the First Time in 30 Years: A New Advancement in Rhabdomyosarcoma Treatment

  According to MedPage Today, a phase III study showed that 6 additional months of chemotherapy for maintenance led to a sizable increase in the 5-year overall survival rate for…

Continue Reading For the First Time in 30 Years: A New Advancement in Rhabdomyosarcoma Treatment